Valuation
- Market cap
- 0
- Revenue TTM
- $1,360,000
- Net income TTM
- $-1,580,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -116.18%
- Debt to equity
- 0.00
Trading
- Volume
- 700
- Avg volume
- 6,582
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- 50%
- Beta
- 1.59
- Analysts
- —
- Price target
- —
Company profile
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as edu...
Show more
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 303-309-0105
- Address
- 3888 East Mexico Avenue, Suite 202, Denver, United States
Latest news
No headlines yet.
